Loading…
ARKA Clinical Decision Support is designed to meet all four criteria for Non-Device CDS under FD&C Act §520(o)(1)(E) and FDA's January 2026 final guidance on Clinical Decision Support Software. Recommendations support, not replace, the clinician's judgment. Every recommendation is anchored in a published guideline or peer-reviewed source, with the basis available for independent review. CLIN emphasizes imaging appropriateness at order entry.
This recommendation is intended to support, not replace, clinical judgment. It is generated by ARKA, software designed to meet the four criteria for Non-Device Clinical Decision Support under FD&C Act §520(o)(1)(E) and FDA's final guidance on Clinical Decision Support Software (January 2026). The clinician is responsible for the final decision.
AIIE Evidence
A documented 4–6 week conservative trial precedes advanced imaging for uncomplicated presentations; red flags and progressive deficits are the exceptions.
For uncomplicated musculoskeletal and back pain presentations, randomized evidence shows early imaging does not improve pain, function, or satisfaction — while incidental findings anchor patients to structural narratives and drive intervention cascades. A documented conservative trial is the guideline-based first step.
The AIIE synthesis above is ARKA-authored; the sources below are the underlying external literature.
The Lancet · 2009doi:10.1016/S0140-6736(09)60172-0
Annals of Internal Medicine · 2017doi:10.7326/M16-2367
The Lancet · 2018doi:10.1016/S0140-6736(18)30480-X
